The Food and Drug Administration cut the time it takes to approve drugs by 40 percent from 1987 to 1992, according to a study released Tuesday.
But a key Republican senator said there’s room for improvement.
“I believe that time can be shortened considerably more … if Congress makes changes now in the way the FDA operates,” said Sen. Nancy Kassebaum, R-Kan.
The study found that 44 percent of the drugs submitted were turned down as unsafe or ineffective or the makers decided not to pursue them.
sponsored Jargon is confusing, by definition. And the financial world has its own set of cryptic words.